Sensory gating deficit is associated with catechol-O-methyltransferase polymorphisms in bipolar disorder

References

• Adler CM, Delbello MP, Strakowski SM. 2006. Brain network dysfunction in bipolar disorder. CNS Spectr 11: 312–320.
   PubMed Web of Science ®Google Scholar
• Adler LE, Hoffer LD, Wiser A, Freedman R. 1993. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150:1856–1861.
   PubMed Web of Science ®Google Scholar
• Alsobrook JP, Zohar AH, Leboyer M, Chabane N, Ebstein RP, Pauls DL. 2002. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet 114:116–120.
   PubMed Web of Science ®Google Scholar
• Arnfred SM, Chen AC. 2004. Exploration of somatosensory P50 gating in schizophrenia spectrum patients: reduced P50 amplitude correlates to social anhedonia. Psychiatry Res 125: 147–160.
   Google Scholar
• Bilder RM, Volavka J, Lachman HM, Grace AA. 2004. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29:1943–1961.
   PubMed Web of Science ®Google Scholar
• Boudikova B, Szumlanski C, Maidak B, Weinshilboum R. 1990. Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 48:381–389.
   PubMed Web of Science ®Google Scholar
• Boutros NN, Gooding D, Sundaresan K, Burroughs S, Johanson CE. 2006. Cocaine-dependence and cocaine-induced paranoia and mid-latency auditory evoked responses and sensory gating. Psychiatry Res 145:147–154.
   PubMed Web of Science ®Google Scholar
• Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, . 2003. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73:152–161.
   PubMed Web of Science ®Google Scholar
• Burdick KE, Funke B, Goldberg JF, Bates JA, Jaeger J, Kucherlapati R, . 2007. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disord 9:370–376.
   PubMed Web of Science ®Google Scholar
• Cerullo MA, Adler CM, Delbello MP, Strakowski SM. 2009. The functional neuroanatomy of bipolar disorder. Int Rev Psychiatry 21:314–322.
   PubMed Web of Science ®Google Scholar
• Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, . 2004. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807–821.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Mackey K, Drews R, Wilfinger W. 1997. DNAzol: a reagent for the rapid isolation of genomic DNA. Biotechniques 22:550–553.
   Google Scholar
• Cousins DA, Butts K, Young AH. 2009. The role of dopamine in bipolar disorder. Bipolar Disord 11:787–806.
   PubMed Web of Science ®Google Scholar
• Croft RJ, Lee A, Bertolot J, Gruzelier JH. 2001. Associations of P50 suppression and desensitization with perceptual and cognitive features of “unreality” in schizotypy. Biol Psychiatry 50:441–446.
   PubMed Web of Science ®Google Scholar
• Csomor PA, Stadler RR, Feldon J, Yee BK, Geyer MA, Vollenweider FX. 2008. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 33: 497–512.
   PubMed Web of Science ®Google Scholar
• Díaz-Asper CM, Weinberger DR, Goldberg TE. 2006. Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics. NeuroRx 3:97–105.
   Google Scholar
• Diaz-Asper CM, Goldberg TE, Kolachana BS, Straub RE, Egan MF, Weinberger DR. 2008. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biol Psychiatry 63:72–79.
   PubMed Web of Science ®Google Scholar
• Dickinson D, Elvevag B. 2009. Genes, cognition and brain through a COMT lens. Neuroscience 164:72–87.
   PubMed Web of Science ®Google Scholar
• Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, . 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917–6922.
   PubMed Web of Science ®Google Scholar
• Freedman R, Adler LE, Gerhardt GA, Waldo M, Baker N, Rose GM, . 1987. Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull 13:669–678.
   PubMed Web of Science ®Google Scholar
• Funke B, Malhotra AK, Finn CT, Plocik AM, Lake SL, Lencz T, . 2005. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 1:19.
   PubMed Web of Science ®Google Scholar
• Goghari VM, Sponheim SR. 2008. Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder. Schizophr Res 103: 186–191.
   PubMed Web of Science ®Google Scholar
• Grunwald T, Boutros NN, Pezer N, von Oertzen J., Fernandez G, Schaller C, . 2003. Neuronal substrates of sensory gating within the human brain. Biol Psychiatry 53:511–519.
   PubMed Web of Science ®Google Scholar
• Hajek T, Carrey N, Alda M. 2005. Neuroanatomical abnormalities as risk factors for bipolar disorder. Bipolar Disord 7: 393–403.
   PubMed Web of Science ®Google Scholar
• Hall MH, Schulze K, Sham P, Kalidindi S, McDonald C, Bramon E, . 2008. Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression: a combined twin and family study. Am J Med Genet B Neuropsychiatr Genet 147B:619–627.
   PubMed Web of Science ®Google Scholar
• Harrison PJ, Tunbridge EM. 2008. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 33:3037–3045.
   PubMed Web of Science ®Google Scholar
• Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10:40–68.
   PubMed Web of Science ®Google Scholar
• Hoenicka J, Garrido E, Martinez I, Ponce G, Aragues M, Rodriguez-Jimenez R, . 2010a . Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 153B: 79–85.
   Google Scholar
• Hoenicka J, Garrido E, Ponce G, Rodriguez-Jimenez R, Martinez I, Rubio G, . 2010b. Sexually dimorphic interaction between the DRD1 and COMT genes in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 153B:948–954.
   Google Scholar
• Katerberg H, Cath DC, Denys DA, Heutink P, Polman A, van Nieuwerburgh FC, . 2010. The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 153B:167–176.
   Google Scholar
• Kirov G, Jones I, McCandless F, Craddock N, Owen MJ. 1999. Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5. Mol Psychiatry 4: 558–565.
   PubMed Web of Science ®Google Scholar
• Knight RT, Staines WR, Swick D, Chao LL. 1999. Prefrontal cortex regulates inhibition and excitation in distributed neural networks. Acta Psychol (Amsterdam) 101:159–178.
   PubMed Web of Science ®Google Scholar
• Knott V, Millar A, Fisher D, Albert P. 2010. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. Neuroscience 166:145–156.
   PubMed Web of Science ®Google Scholar
• Kremer I, Pinto M, Murad I, Muhaheed M, Bannoura I, Muller DJ, . 2003. Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. Am J Med Genet B Neuropsychiatr Genet 119B: 35–39.
   Google Scholar
• Leonard S, Adams C, Breese CR, Adler LE, Bickford P, Byerley W, . 1996. Nicotinic receptor function in schizophrenia. Schizophr Bull 22:431–445.
   PubMed Web of Science ®Google Scholar
• Levy F. 2008. Pharmacological and therapeutic directions in ADHD: Specificity in the PFC. Behav Brain Funct 4:12.
   PubMed Web of Science ®Google Scholar
• Light GA, Malaspina D, Geyer MA, Luber BM, Coleman EA, Sackeim HA, . 1999. Amphetamine disrupts P50 suppression in normal subjects. Biol Psychiatry 46:990–996.
   Google Scholar
• Lijffijt M, Moeller FG, Boutros NN, Steinberg JL, Meier SL, Lane SD, . 2009. Diminished P50, N100 and P200 auditory sensory gating in bipolar I disorder. Psychiatry Res 167: 191–201.
   Google Scholar
• Lu BY, Martin KE, Edgar JC, Smith AK, Lewis SF, Escamilla MA, . 2007. Effect of catechol o-methyltransferase val(158)met polymorphism on the p50 gating endophenotype in schizophrenia. Biol Psychiatry 62:822–825.
   PubMed Web of Science ®Google Scholar
• Mackey K, Williams P, Seim S, Chomczynski P. 1996. The use of DNAzol for the rapid isolation of genomic DNA from whole blood. Biomed Prod Suppl 13–15.
   Google Scholar
• Mann C, Croft RJ, Scholes KE, Dunne A, O'Neill BV, Leung S, . 2008. Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans. Neuropsychopharmacology 33:1653–1666.
   Google Scholar
• Meyer-Lindenberg A, Kohn PD, Kolachana B, Kippenhan S, Inerney-Leo A, Nussbaum R, . 2005. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 8:594–596.
   PubMed Web of Science ®Google Scholar
• Mier D, Kirsch P, Meyer-Lindenberg A. 2009. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry.
   Google Scholar
• Moxon KA, Gerhardt GA, Adler LE. 2003. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relation ship to sensory gating in schizophrenia. Biol Cybernet 88: 265–275.
   Google Scholar
• Myles-Worsley M. 2002. P50 sensory gating in multiplex schizophrenia families from a Pacific island isolate. Am J Psychiatry 159:2007–2012.
   PubMed Web of Science ®Google Scholar
• Nagamoto HT, Adler LE, Waldo MC, Griffith J, Freedman R. 1991. Gating of auditory response in schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave. Schizophr Res 4:31–40.
   PubMed Web of Science ®Google Scholar
• Nolan KA, Bilder RM, Lachman HM, Volavka J. 2004. Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiatry 161:359–361.
   PubMed Web of Science ®Google Scholar
• Olincy A, Martin L. 2005. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am J Psychiatry 162:43–49.
   PubMed Web of Science ®Google Scholar
• Palmatier MA, Pakstis AJ, Speed W, Paschou P, Goldman D, Odunsi A, . 2004. COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol Psychiatry 9:859–870.
   PubMed Web of Science ®Google Scholar
• Prata DP, Breen G, Munro J, Sinclair M, Osborne S, Li T, . 2006. Bipolar 1 disorder is not associated with the RGS4, PRODH, COMT and GRK3 genes. Psychiatr Genet 16: 229–230.
   Google Scholar
• Sanchez-Morla EM, Garcia-Jimenez MA, Barabash A, Martinez-Vizcaino V, Mena J, Cabranes-Diaz JA, . 2008. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia. Acta Psychiatr Scand 117:313–318.
   PubMed Web of Science ®Google Scholar
• Santos JL, Sanchez-Morla EM, Aparicio A, Garcia-Jimenez MA, Villanueva C, Martinez-Vizcaino V, . 2010. P50 gating in deficit and nondeficit schizophrenia. Schizophr Res 119: 183–190.
   PubMed Web of Science ®Google Scholar
• Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. 2002. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70: 425–434.
   PubMed Web of Science ®Google Scholar
• Schulze KK, Hall MH, McDonald C, Marshall N, Walshe M, Murray RM, . 2007. P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives. Biol Psychiatry 62:121–128.
   PubMed Web of Science ®Google Scholar
• Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI. 1998. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18:2697–2708.
   PubMed Web of Science ®Google Scholar
• Shaikh M, Hall MH, Schulze K, Dutt A, Walshe M, Williams I, . 2010. Do COMT, BDNF and NRG1 polymorphisms influence P50 sensory gating in psychosis? Psychol Med1–14.
   Google Scholar
• Shifman S, Bronstein M, Sternfeld M, Pisante A, Weizman A, Reznik I, . 2004. COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 128:61–64.
   Google Scholar
• Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, . 2002. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71:1296–1302.
   PubMed Web of Science ®Google Scholar
• Sinnwell JP, Schaid DJ. haplo.stats: Statistical analysis of haplotypes with traits and covariates when linkage phase is ambiguous. R package version 1.2.2. 2005.
   Google Scholar
• Ref Type: Computer Program.
   Google Scholar
• Strakowski SM, Delbello MP, Adler CM. 2005. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry 10:105–116.
   PubMed Web of Science ®Google Scholar
• Tan HY, Callicott JH, Weinberger DR. 2007. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb Cortex 17(Suppl 1): i171–i181.
   Google Scholar
• Tunbridge EM, Harrison PJ, Weinberger DR. 2006. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 60:141–151.
   PubMed Web of Science ®Google Scholar
• van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W. 1998. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 55:41–46.
   PubMed Web of Science ®Google Scholar
• Venables PH. 1967. Input dysfunction in schizophrenia. In: Maher BA. Progress in experimental personality research. Orlando, FL: Academic Press.
   Google Scholar
• Waldo MC, Cawthra E, Adler LE, Dubester S, Staunton M, Nagamoto H, et al . 1994. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schizophr Res 12:93–106.
   Google Scholar
• Wang Z, Xiao Z, Inslicht SS, Tong H, Jiang W, Wang X, . 2009. Low expression of catecholamine-O-methyl-transferase gene in obsessive-compulsive disorder. J Anxiety Disord 23:660–664.
   Google Scholar
• Winterer G, Goldman D. 2003. Genetics of human prefrontal function. Brain Res Brain Res Rev 43:134–163.
   PubMedGoogle Scholar
• Wirgenes KV, Djurovic S, Sundet K, Agartz I, Mattingsdal M, Athanasiu L, . 2010. Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls. Schizophr Res 122:31–7.
   PubMed Web of Science ®Google Scholar
• Xie T, Ho SL, Ramsden D. 1999. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56: 31–38.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lindpaintner K, Che R, He Z, Wang P, Yang P, . 2009. The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis. J Neural Transm 116: 1193–1200.
   PubMed Web of Science ®Google Scholar